These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, Roux C, Maugars Y, Mulleman D, Lukas C, Wendling D, Lafforgue P, Loeuille D, Foltz V, Richette P, French section of osteoarthritis. Ann Rheum Dis; 2015 Sep; 74(9):1697-705. PubMed ID: 24817417 [Abstract] [Full Text] [Related]
4. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial. Detert J, Klaus P, Listing J, Höhne-Zimmer V, Braun T, Wassenberg S, Rau R, Buttgereit F, Burmester GR. Trials; 2014 Oct 27; 15():412. PubMed ID: 25348033 [Abstract] [Full Text] [Related]
10. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Kloppenburg M, Ramonda R, Bobacz K, Kwok WY, Elewaut D, Huizinga TWJ, Kroon FPB, Punzi L, Smolen JS, Vander Cruyssen B, Wolterbeek R, Verbruggen G, Wittoek R. Ann Rheum Dis; 2018 Dec 27; 77(12):1757-1764. PubMed ID: 30282670 [Abstract] [Full Text] [Related]
11. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Kloppenburg M, Peterfy C, Haugen IK, Kroon F, Chen S, Wang L, Liu W, Levy G, Fleischmann RM, Berenbaum F, van der Heijde D, Bansal P, Wittoek R, Feng S, Fang Y, Saltarelli M, Medema JK, Levesque MC. Ann Rheum Dis; 2019 Mar 27; 78(3):413-420. PubMed ID: 30552176 [Abstract] [Full Text] [Related]
12. The responsiveness of joint counts, patient-reported measures and proposed composite scores in hand osteoarthritis: analyses from a placebo-controlled trial. Haugen IK, Slatkowsky-Christensen B, Lessem J, Kvien TK. Ann Rheum Dis; 2010 Aug 27; 69(8):1436-40. PubMed ID: 19508966 [Abstract] [Full Text] [Related]
17. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. J Rheumatol; 2003 Dec 27; 30(12):2563-71. PubMed ID: 14719195 [Abstract] [Full Text] [Related]
18. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Barthel HR, Peniston JH, Clark MB, Gold MS, Altman RD. Arthritis Res Ther; 2010 Dec 27; 12(1):R7. PubMed ID: 20064249 [Abstract] [Full Text] [Related]
19. Bone marrow lesions on magnetic resonance imaging in hand osteoarthritis are associated with pain and interact with synovitis. Liu R, Damman W, Reijnierse M, Bloem JL, Rosendaal FR, Kloppenburg M. Osteoarthritis Cartilage; 2017 Jul 27; 25(7):1093-1099. PubMed ID: 28216312 [Abstract] [Full Text] [Related]
20. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Axelsen MB, Eshed I, Hørslev-Petersen K, Stengaard-Pedersen K, Hetland ML, Møller J, Junker P, Pødenphant J, Schlemmer A, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Krogh NS, Johansen JS, Østergaard M, OPERA study group. Ann Rheum Dis; 2015 May 27; 74(5):867-75. PubMed ID: 24412895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]